Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α.
Mira E, Carmona-Rodríguez L, Pérez-Villamil B, Casas J, Fernández-Aceñero MJ, Martínez-Rey D, Martín-González P, Heras-Murillo I, Paz-Cabezas M, Tardáguila M, Oury TD, Martín-Puig S, Lacalle RA, Fabriás G, Díaz-Rubio E, Mañes S. Mira E, et al. Among authors: paz cabezas m. Nat Commun. 2018 Feb 8;9(1):575. doi: 10.1038/s41467-018-03079-1. Nat Commun. 2018. PMID: 29422508 Free PMC article.
SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Carmona-Rodríguez L, Martínez-Rey D, Fernández-Aceñero MJ, González-Martín A, Paz-Cabezas M, Rodríguez-Rodríguez N, Pérez-Villamil B, Sáez ME, Díaz-Rubio E, Mira E, Mañes S. Carmona-Rodríguez L, et al. Among authors: paz cabezas m. J Immunother Cancer. 2020 Jun;8(1):e000432. doi: 10.1136/jitc-2019-000432. J Immunother Cancer. 2020. PMID: 32591431 Free PMC article.
Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer.
Cabezas-Camarero S, Cabrera-Martín MN, Merino-Menéndez S, Paz-Cabezas M, García-Barberán V, Sáiz-Pardo Sanz M, Iglesias-Moreno M, Alonso-Ovies A, Pérez-Segura P. Cabezas-Camarero S, et al. Among authors: paz cabezas m. Oncologist. 2021 Jun;26(6):e1018-e1035. doi: 10.1002/onco.13754. Epub 2021 Apr 8. Oncologist. 2021. PMID: 33751752 Free PMC article.
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.
Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V. Pérez-Segura P, et al. Among authors: paz cabezas m. Med Clin (Barc). 2021 Oct 8;157(7):318-324. doi: 10.1016/j.medcli.2021.02.021. Epub 2021 May 6. Med Clin (Barc). 2021. PMID: 34154809 Free PMC article.
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.
Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V. Pérez-Segura P, et al. Among authors: paz cabezas m. Med Clin (Engl Ed). 2021 Oct 8;157(7):318-324. doi: 10.1016/j.medcle.2021.02.010. Epub 2021 Oct 4. Med Clin (Engl Ed). 2021. PMID: 34632069 Free PMC article.
Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers.
Tesolato S, Vicente-Valor J, Paz-Cabezas M, Gómez-Garre D, Sánchez-González S, Ortega-Hernández A, de la Serna S, Domínguez-Serrano I, Dziakova J, Rivera D, Jarabo JR, Gómez-Martínez AM, Hernando F, Torres A, Iniesta P. Tesolato S, et al. Among authors: paz cabezas m. Biomedicines. 2024 Mar 21;12(3):703. doi: 10.3390/biomedicines12030703. Biomedicines. 2024. PMID: 38540316 Free PMC article.
Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets.
Paz-Cabezas M, Calvo-López T, Romera-Lopez A, Tabas-Madrid D, Ogando J, Fernández-Aceñero MJ, Sastre J, Pascual-Montano A, Mañes S, Díaz-Rubio E, Perez-Villamil B. Paz-Cabezas M, et al. Cancers (Basel). 2022 Oct 22;14(21):5175. doi: 10.3390/cancers14215175. Cancers (Basel). 2022. PMID: 36358609 Free PMC article.